Skip to main content

Homepage

Latest News

Sign up for the webinar on IMI's impact on dementia

IMI has a large portfolio of projects focusing on dementia covering the whole spectrum of medical research and drug development, including the role of specific genes in the disease, how to identify those at risk of the disease, and how to improve diagnosis, management, and the development of new treatments. A webinar on Tuesday 15 June will explore the impact of IMI's projects in this important field. This is the third in a series of events on IMI's impact - the first two focused on IMI's impact on diabetes and health data.

/news-events/events/imi-impact-dementia-event
/news-events/events/imi-impact-dementia-event

New institute to act as catalyst for wider use of real-world evidence in healthcare decision-making in Europe

New institute to act as catalyst for wider use of real-world evidence in healthcare decision-making in Europe  more

The scale of the funding enables real impact

The scale of the funding enables real impact  more

The real cost of RSV, a common but often fatal disease

The real cost of RSV, a common but often fatal disease  more

 

 

IMI – radical collaboration in action

A new brochure, 'IMI - radical collaboration in action', showcases some recent IMI project successes, which include an approved vaccine for Ebola, insights into the genetics of Alzheimer’s disease, a new classification of diabetes, and advances on using liquid biopsies for cancer, as well as contributions to the fight against COVID-19.

 more

dna.jpg

 

 

 

IMI covid-19 response

 

Within weeks of the first reports of coronavirus in Europe, IMI launched a fast-track Call for proposals to develop therapeutics and diagnostics for current and future coronavirus outbreaks

 

ddd